ADCs Toxicities: Optimizing Patient Management and Outcomes
Activity Overview
The GOG Foundation, Inc. and GOG Partners presents the ADC’s Toxicities: Optimizing Patient Management and Outcomes, an Independent Satellite Symposium at the SGO 2023 Winter Annual Meeting. Physician leadership will provide an educational symposium that will focus on the novel therapeutic agents available and designed to target specific ovarian and cervical cancer tumor cells. They will review the advancements in treatment options currently available. Our expert leaders will share the emerging data and outline how to integrate these treatments into clinical practice. Additionally, the discussion will revolve around how to best manage ocular or other adverse events with ADCs. This symposium will be offered both in person and virtually.
The GOG Foundation, Inc. and GOG Partners would like to thank our commercial supporters for their unrestricted educational grants associated with this Symposium: Immunogen, Seagen, Inc. and Genmab
Target Audience
The target audience for this activity is community and academic gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other providers who treat patients with gynecologic malignancies.
Learning Objectives
Upon completion of the activities in this series, learners will demonstrate:
- Understanding targeted drug therapy as a treatment for patients with ovarian and cervical;
- Increased knowledge regarding all advance treatments available for ovarian and cervical cancer;
- Identify toxicities and understand management for best treatment;
- Learn how to best implement treatment into practice to improve patient outcomes.
Goal of Symposium
The goal of this symposia is to increase clinicians’ knowledge and competence regarding the various targeted drug conjugates available. Learners will also understand how to best implement these advance treatments into clinical practice.
Moderator
Dr. Robert Coleman
Faculty
Dr. Ramez Eskander
Dr. David O’Malley
Dr. Angeles Alvarez Secord
Dr. R. Wendel Naumann
Dr. Megan Berkenstock
Agenda & Presentation Materials
ADC’s Toxicities: Optimizing Patient Management and Outcomes, a Independent Satellite Symposium at the SGO 2023 Winter Annual Meeting
Presented on Thursday, February 2, 2023, 8:00 pm – 9:30 pm PST
Enduring Educational Materials will be available on demand for six months following the live virtual presentation.
To access the recording of this symposium, please click the button below. Once you have completed the registration, a confirmation email will be sent to the email address you provide and will include a link to access the recording. To view the presentation slides, you may click the View Presentation links in the agenda below.
In Person Attendees
Robert Coleman, MD, US Oncology Research Network, The Woodlands, Texas, USA
Ramez Eskander, MD, UC San Diego, San Diego, California, USA
Angeles Alvarez Secord, MD, Duke University, Chapel Hill, North Carolina, USA
David O’Malley, MD, The Ohio State University, James Cancer Center, Columbus, Ohio, USA
Megan Berkenstock, MD, Johns Hopkins, Baltimore, MD
All Faculty
Wendel Naumann, MD, Atrium Health, Charlotte, North Carolina, USA
Continuing Education
In support of improving patient care, this activity has been planned and implemented by The GOG Foundation, Inc. (GOG).
Accreditation Statement
The GOG Foundation, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education for physicians.
AMA PRA Category 1 Credits™
The GOG Foundation, Inc. designates this on demand activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Method of Participation
There are no fees for participating in and receiving CME credit for this activity. Participants must: 1) read the educational objectives and faculty disclosures; 2) attend the educational activity; 3) email our educational team at info@gog.org to receive and complete the educational evaluation.
Participants who complete the educational activity and evaluation will receive a certificate of credit.
Disclosure Declaration
In accordance with the ACCME Accreditation Criteria, The GOG Foundation, Inc., as the accredited provider of this activity, must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any ineligible company *(formally known as commercial interests). All Committee/Planning/Faculty members were required to disclose all financial relationships and speakers were required to disclose any financial relationship as it pertains to the content of the presentations. All relevant financial relationships listed for these individuals have been mitigated to ensure a bias-free presentation. Please see the faculty disclosure list for detailed information.
- Robert Coleman, MD, US Oncology Research Network, The Woodlands, Texas, USA
- Ramez Eskander, MD, UC San Diego, San Diego, California, USA
- David O’Malley, MD, The Ohio State University, James Cancer Center, Columbus, Ohio, USA
- Angeles Alvarez Secord, MD, Duke University, Chapel Hill, North Carolina, USA
- R. Wendel Naumann, MD, Atrium Health, Charlotte, North Carolina, USA
- Megan Berkenstock, MD, Wilmer Eye Institute of the Johns Hopkins School of Medicine, Baltimore, MD
Technical Requirements
For those participating in this activity virtually, it is best experienced using the most current browser (or one back) of Firefox, Chrome, Safari, Internet Explorer, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers.